<?xml version="1.0" encoding="UTF-8"?>
<ref id="bibr39">
 <label>39</label>
 <mixed-citation publication-type="book">
  <collab>US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER)</collab>. 
  <article-title>Guidance for Industry. E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs.</article-title>
  <publisher-loc>Rockville (MD)</publisher-loc>: 
  <publisher-name>US Department of Health and Human Services</publisher-name>; 
  <year>2005</year>.
 </mixed-citation>
</ref>
